Copper (II) complexes modified with water-soluble porphyrin and various small molecules ligand for DNA binding and potential selectivity antitumor agents
Source abstract
Abstract
Abstract Many strategies have been used in treatment of cancer, but currently the chemotherapy is still the main force, unfortunately, general agents exhibit inevitable toxicity and inferior selectivity. Therefore, less toxic and high selectivity anticancer reagents have been extensively sought and developed. Here we report a series of Copper (II) complexes CuP1~CuP5 which have good biological activities. Due to the influence of the molecular size, CuP1 displayed the strongest bound with ct-DNA. All of the complexes show positive anticancer activities toward A549, H1975, HepG2 and T47D cancer cells. Additionally, flow cytometry experiments indicated that complexe CuP2 arrest cell cycles at S and G2 phase and mitochondrial membrane potential tests were also performed to explore the mechanism of action. Our findings disclosed that this type of complex represents a potent platform for development of metal anticancer drugs.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Metal complexes synthesis and properties · Porphyrin and Phthalocyanine Chemistry · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (66)
Show source-provided references
1. Multifunctional theranostic nanoplatform based on Fe-mTa2O5@CuS-ZnPc/PCM for bimodal imaging and synergistically enhanced phototherapy10.1021/acs.inorgchem.7b02959 ↗
2. Comprehensive molecular portraits of human breast tumours10.1038/nature11412 ↗
3. Ruthenium complexes as antimicrobial agents10.1039/C4CS00343H ↗
4. Syntheses and photophysical properties of schiff base Ni(II) complexes: application for sustainable antibacterial activity and cytotoxicity10.1021/acssuschemeng.7b00963 ↗
5. Axial ligand exchange of N-heterocyclic cobalt(III) schiff base complexes: molecular structure and NMR solution dynamics10.1021/ic302379j ↗
6. Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways10.1021/ja4075375 ↗
7. Interactions of antitumor metallodrugs with serum Proteins: advances in characterization using modern analytical methodology10.1021/cr040704h ↗
8. Exploration of the medical periodic table: towards new targets10.1039/c3cc41143e ↗
9. Noble metals in medicine: latest advances10.1016/j.ccr.2014.08.002 ↗
10. Copper in diseases and treatments, and copper-based anticancer strategies10.1002/med.20174 ↗
11. Developing anticancer copper(II) pro-drugs based on the nature of cancer cells and the human serum albumin carrier IIA subdomain10.1021/acs.molpharmaceut.5b00314 ↗
12. Developing anticancer ferric prodrugs based on the N-donor residues of human serum albumin carrier IIA subdomain10.1021/acs.jmedchem.6b00509 ↗
13. Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes10.1158/0008-5472.CAN-11-1218 ↗
14. Photodynamic therapy (PDT): PDT mechanisms10.5946/ce.2013.46.1.24 ↗
15. Photodynamic therapy of cancer: an update
16. Novel amphiphilic cationic porphyrin and its Ag(II) complex as potential anticancer agents10.1016/j.jinorgbio.2014.06.013 ↗
17. From achiral porphyrins to template-imprinted chiral aggregates and further. Self-replication of chiral memory from scratch10.1021/ja017159b ↗
18. Cationic porphyrins are reversible proteasome inhibitors10.1021/ja300781u ↗
19. Triplet-state dynamics of a metalloporphyrin photosensitiser (PtTMPyP4) in the presence of halides and purine mononucleotides10.1039/c1pp05125c ↗
20. Fluorescence quenching effect of guanine interacting with water-soluble cationic porphyrin10.1016/j.jlumin.2013.10.061 ↗
21. Anticancer effect and mechanism of a Se-modified porphyrin Au(III) complex10.1016/j.bmcl.2015.06.075 ↗
22. Doxorubicin-loaded redox-responsive amphiphilic dendritic porphyrin conjugates for chemotherapy and photodynamic therapy10.1039/C6RA09356F ↗
23. Metal–organic framework nanoshuttle for synergistic photodynamic and low-temperature photothermal therapy10.1002/adfm.201804634 ↗
24. Smart peptide-based supramolecular photodynamic metallo-nanodrugs designed by multicomponent coordination self-assembly10.1021/jacs.8b04912 ↗
25. Synthesis, structure, and reactivity of ruthenium carboxylato and 2-oxocarboxylato complexes bearing the bis(3,5-dimethylpyrazol-1-yl)acetato ligand10.1021/ic8000224 ↗
26. Effect of water concentration and acidity on the synthesis of porous chromium benzenedicarboxylates10.1002/ejic.200901064 ↗
27. DNA interaction studies of a novel Cu(II) complex as an intercalator containing curcumin and bathophenanthroline ligands10.1016/j.jphotobiol.2013.03.002 ↗
28. Polynuclear and 1-D derivatives of 1,3-bis(dimethylamino)-2-propanolato ligand. Structure and magnetic characterization10.1039/b402629b ↗
29. Synthesis and crystal structures of cyclodiazastannoxides fused cyclopentadienyl M-Sn (M= Mo, W) bonded organometallic heterocycle10.1016/j.jorganchem.2005.06.027 ↗
30. A stabilizing and denaturing dual-effect for natural polyamines interacting with G-quadruplexes depending on concentration10.1016/j.biochi.2011.06.007 ↗
31. Photoprocesses of copper complexes that bind to DNA10.1021/cr9601167 ↗
32. Synthesis and structural characterization of some divalent metal complexes: DNA binding and antitumor activity10.1016/j.molliq.2017.07.009 ↗
33. Synthesis, characterization, DNA binding and antitumor activities of Cu(II) complexes10.1016/j.molliq.2018.08.075 ↗
34. Molecular complexes of nucleosides and nucleotides with a monomeric cationic porphyrin and some of its metal derivatives10.1021/ja00312a061 ↗
35. Preparation and electronic structure of substituted aromatic dithiolene complexes of gold(III)10.1021/ic00118a016 ↗
36. A spectroscopic study on the interactions of porphyrin with G-quadruplex DNAs10.1021/bi052356z ↗
37. Synthesis, spectroscopic, crystal structure and DNA binding of Ru(II) complexes with 2-hydroxy-benzoic acid [1-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)-ethylidene]-hydrazide10.1016/j.saa.2011.05.069 ↗
38. Synthesis, structure, DNA/BSA binding and antibacterial studies of NNO tridentate Schiff base metal complexes10.1016/j.molstruc.2017.08.040 ↗
39. Induction of cell death by ternary copper(II) complexes of l-tyrosine and diimines: role of coligands on DNA binding and cleavage and anticancer activity10.1021/ic801144x ↗
40. Antiangiogenic activity of mononuclear copper(II) polypyridyl complexes for the treatment of cancers10.1021/acs.jmedchem.5b00651 ↗
41. Studies on the interaction of diacetylcurcumin with calf thymus-DNA10.1016/j.chemphys.2008.05.008 ↗
42. Synthesis, characterization and DNA-binding properties of La(III) complex of chrysin10.1016/S0162-0134(03)00313-1 ↗
43. Use of UV-vis spectrometry to gain information on the mode of binding of small molecules to DNAs and RNAs10.1080/05704928.2011.641044 ↗
44. Interaction of 7-hydroxyflavone with human serum albumin: a spectroscopic study10.1016/j.jphotobiol.2007.10.005 ↗
45. Probing protein binding sites by circular dichroism spectroscopy10.2174/1570163043335135 ↗
46. Systematic investigation on the central metal ion dependent binding geometry of M-meso-tetrakis(N-methylpyridinium-4-yl)porphyrin to DNA and their efficiency as an acceptor in DNA-mediated energy transfer10.1021/jp212291r ↗
47. Interaction of Metallo- and free base meso-tetrakis(N-methylpyridium-4-yl)porphyrin with a G-quadruplex: effect of the central metal ions10.1016/j.bpc.2014.03.005 ↗
48. Interaction of [Ru(dmp)2(dppz)]2+ and [Ru(dmb)2(dppz)]2+ with DNA: effects of the ancillary ligands on the DNA-binding behaviors10.1021/ic001124f ↗
49. Antioxidant, DNA binding and nuclease activities of heteroleptic copper(II) complexes derived from 2-((2-(piperazin-1-yl)ethylimino)methyl)-4-substituted phenols and diimines10.1016/j.saa.2014.06.045 ↗
50. Synthesis, crystal structure and electrochemical and DNA binding studies of oxygen bridged-copper(II) carboxylate10.1016/j.molstruc.2015.03.058 ↗
51. Syntheses, crystal structures and DNA-binding studies of Cu(II) and Zn(II) complexes bearing asymmetrical aroylhydrazone ligand10.1016/j.molstruc.2016.10.092 ↗
52. Interaction study of some macrocyclic inorganic schiff base complexes with calf thymus DNA using spectroscopic and voltammetric methods10.1016/j.molstruc.2017.09.088 ↗
53. Two new neutral copper(II) complexes with dipicolinic acid and 3-amino-1H-1,2,4-triazole formed under different reaction conditions: synthesis, characterization, molecular structures and DNA-binding studies10.1016/j.ejmech.2013.10.009 ↗
54. Synthesis and cytotoxic activity of novel amidine analogues of bis(2-chloroethyl)amine10.1002/ardp.200800231 ↗
55. Preparation characterization, 1H, 13C NMR study and antibacterial studies of schiff bases and their Zn (II) chelates
56. Porphyrin–bile acid conjugates: from saccharide recognition in the solution to the selective cancer cell fluorescence detection10.1039/b717528k ↗
57. Mixed valence copper(I,II) binuclear complexes with unexpected structure: synthesis, biological properties and anticancer activity10.1021/jm500154f ↗
58. Developing anticancer copper(II) pro-drugs based on the nature of cancer cells and the human serum albumin carrier IIA subdomain10.1021/acs.molpharmaceut.5b00314 ↗
59. Developing an anticancer copper(II) pro-drug based on the His 242 residue of the human serum albumin carrier IIA subdomain10.1021/acs.molpharmaceut.5b00938 ↗
60. Mixed-ligand copper(II)-phenolate Complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity10.1021/ic700755p ↗
61. Electron spectroscopy, molecular structures, and binding energies of Al- and Cu-imidazole10.1021/jp0649605 ↗
62. Herbo-mineral based Schiff base ligand and its metal complexes: synthesis, characterization, catalytic potential and biological applications10.1016/j.jphotobiol.2016.03.030 ↗
63. Opposite role of changes in mitochondrial membrane potential in different apoptotic processes10.1016/S0014-5793(00)01266-7 ↗
64. NIR-to-Red upconversion nanoparticles with minimized heating effect for synchronous multidrug resistance tumor imaging and therapy10.1021/acsami.8b00409 ↗
65. UV-emitting upconversion-based TiO2 photosensitizing nanoplatform: near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis pathway10.1021/nn506107c ↗
66. Potent half-sandwich iridium(III) and ruthenium(II) anticancer complexes containing a P∧O-chelated ligand10.1021/acs.organomet.8b00402 ↗